Is Technosphere the monster in the closet?
Aug 16, 2014 7:43:35 GMT -5
4Balance and bradleysbest like this
Post by mnholdem on Aug 16, 2014 7:43:35 GMT -5
The Monster in the Closet
Now that Sanofi is handling all aspects of marketing Afrezza, MannKind can focus on Technosphere and partnering with other Pharmas for various other drug applications. The fact that the company has been redesigning it's website supports this. In response to a question about a possible Merck buyout, Al recently joked that some day MannKind may buyout Merck! What the market hasn't fully grasped yet, because it doesn't understand the science, is that Technosphere is the monster in the closet.
Afrezza has the potential to revolutionize diabetes treatment, but Technosphere has the potential to revolutionize the entire drug industry.
My viewpoint presents a longer view than the market & investors are focusing on at present. Nonetheless, other drug partnership agreements could result in additional upfront payments in the near term, which would significantly improve MannKind's financial health.
It makes me wonder if Al Mann wasn't joking so much as sharing his vision.
Now that Sanofi is handling all aspects of marketing Afrezza, MannKind can focus on Technosphere and partnering with other Pharmas for various other drug applications. The fact that the company has been redesigning it's website supports this. In response to a question about a possible Merck buyout, Al recently joked that some day MannKind may buyout Merck! What the market hasn't fully grasped yet, because it doesn't understand the science, is that Technosphere is the monster in the closet.
Afrezza has the potential to revolutionize diabetes treatment, but Technosphere has the potential to revolutionize the entire drug industry.
My viewpoint presents a longer view than the market & investors are focusing on at present. Nonetheless, other drug partnership agreements could result in additional upfront payments in the near term, which would significantly improve MannKind's financial health.
It makes me wonder if Al Mann wasn't joking so much as sharing his vision.
